HEARTLAB’S CARDIONOW EXPANDS INSTALLATION BASE TO INCLUDE LEADING EUROPEAN INDEPENDENT CONTRACT RESEARCH LABORATORY
Heart Core B.V. deploys Heartlab’s CardioNow internet-based image management solution for cardiovascular clinical trials.
- Press release
- WESTERLY, RI
- July 24, 2004 10:28
Heartlab, the world’s leading designer and supplier of digital image and information networks for cardiology.
Heartlab, the world's leading designer and supplier of digital image and information networks for cardiology, today announced that it has completed its first European core lab installation of Heartlab's CardioNow DICOM telecardiology and image management solution for cardiovascular device and drug studies at Heart Core B.V. in the Netherlands.
Heartlab's web-based CardioNow technology enables hospital investigator sites anywhere in the world to easily share DICOM studies required by certain cardiovascular drug and device clinical trails. Within minutes of initial patient enrollment, study images can be transferred electronically from investigator sites to angiographic and ultrasound core labs anywhere in the world for analysis. Additionally, these studies can be made available online for simultaneous review by other stakeholders such as clinical event committee members, safety monitoring board members and trial sponsors.
Heart Core B.V. will now be able to offer its clients Heartlab's web-based CardioNow solution to expedite and streamline the receiving, tracking, archiving, and analysis of complex cardiac images from hospital investigator sites around the world. This installation represents the fifth cardiovascular core lab to endorse Heartlab's web-based solution for clinical trial image management.
"Heartlab's CardioNow solution for clinical trial image management is appealing to trial sponsors, core labs and investigator sites because it can eliminate the laborious and time- consuming task of physically handling, storing and analyzing these complex images," commented Heartlab CEO Robert Petrocelli. "By utilizing our technology, investigator sites can electronically send these critically important images to the core lab and the trial sponsor in minutes, significantly expediting workflow and decreasing time to market for new devices and drugs that require clinical trails with imaging endpoints. We are extremely excited that a leading European core lab will now be able to offer our innovative solution to their extensive client base."
Managing Director of Heart Core B.V. Anton van Weert, PhD said, "Integration of this technology within our core laboratory services will strengthen our international position as an innovative and high quality service provider of image analysis services. In addition to our cardiovascular expertise including QCA, QVA, IVUS, MRI, ultrasound and SPECT, Heart Core will be the first core lab in the world being able to offer Heartlab's CardioNow solution in non-cardiovascular clinical trials requiring multislice CT of the lungs, neuro-imaging by MR and imaging for orthopedic device evaluation".
Additional information on Heartlab's CardioNow image management solution for clinical trials can be obtained at http://www.heartlab.com/cardionow.htm.
About Heartlab
Heartlab is the world's leading designer and supplier of digital image and information networks for cardiology. Named one of America's fastest-growing private companies for the fourth year in a row by Inc. magazine, Heartlab develops application software and integrates systems using industry-standard computer hardware, including Heartlab's own StoreSafe® DVD-R archiving and Oracle's database technology. Heartlab's Encompass™ network gives cardiologists rapid access to imaging exams and report information, enables cardiology centers to operate more efficiently, and provides robust protection for critical patient data. Heartlab's Encompass networks are installed in more than 225 of the nation's leading heart centers. The company's CardioNow image management solution for clinical trials has been utilized by leading cardiovascular core labs and cardiovascular device and drug companies to expedite the sharing, tracking and analysis of complex cardiac images for over 25 multi-center clinical trials including drug-eluting stent, bare metal stent, as well as distal protection device studies. For more information, visit www.Heartlab.com.
About Heart Core B.V.
Heart Core is an independent contract research laboratory for quantitative analysis and management of medical images in clinical trials. Heart Core provides services to the pharmaceutical, medical device, biotechnology and contrast agent industry. Based in the Netherlands, Heart Core receives image acquisitions from investigator sites around the world. To date, Heart Core offers quantitative image analysis services for the largest variety of image modalities. For more information, visit http://www.heartcore.nl.